Home > Share Market > Stocks > Jubilant pharmova > Financial Statements > JUBLPHARMA Key Financial Ratios

Jubilant pharmova Financial Statements

Jubilant pharmova Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (33) 21.80 28.30 1.95
Op profit growth (28) 28.20 12.90 7.89
EBIT growth (30) 34 5.99 18.10
Net profit growth (6.90) 39.70 11.70 46.90
Profitability ratios (%)        
OPM 22.90 21.30 20.20 23
EBIT margin 17.50 16.70 15.20 18.40
Net profit margin 13.70 9.81 8.55 9.82
RoCE 11.50 16.70 15 14.20
RoNW 4.04 4.63 4.27 4.50
RoA 2.26 2.45 2.10 1.89
Per share ratios ()        
EPS 52.50 56.40 40.70 36.90
Dividend per share 5 5 3 3
Cash EPS 30.60 27.40 14.60 18.30
Book value per share 298 352 262 221
Valuation ratios        
P/E 13 3.83 17.90 18.80
P/CEPS 22.30 7.88 49.80 38
P/B 2.29 0.61 2.78 3.14
EV/EBIDTA 9.19 3.70 10.70 11.90
Payout (%)        
Dividend payout -- -- 7.27 8.12
Tax payout (34) (25) (26) (22)
Liquidity ratios        
Debtor days 63.20 48.30 51.90 60.90
Inventory days 89 64.50 63.40 75.50
Creditor days (65) (58) (60) (58)
Leverage ratios        
Interest coverage (5.80) (5.30) (4) (3.20)
Net debt / equity 0.46 0.61 0.79 1.04
Net debt / op. profit 1.55 1.75 2.12 2.67
Cost breakup ()        
Material costs (25) (34) (38) (34)
Employee costs (32) (23) (21) (21)
Other costs (20) (21) (21) (22)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000